TRANCE/TNFSF11/RANK L Antibody [Unconjugated]

Images

 
In the presence of Recombinant Mouse M‑CSF (20 ng/mL, Catalog # 416-ML), Recombinant Mouse TRANCE/TNFSF11/RANK L (Catalog # 462-TR) induces osteoclast-like cell formation in mouse splenocytes in a dose-dependent ...read more

Product Details

Summary
Reactivity MuSpecies Glossary
Applications WB, IHC, B/N, ELISA(Cap)
Clonality
Polyclonal
Host
Goat
Conjugate
Unconjugated
Concentration
LYOPH

Order Details

View Available Conjugates
Catalog# & Conjugate Size Price
View Available Formulations
Catalog# & Formulation Size Price

TRANCE/TNFSF11/RANK L Antibody [Unconjugated] Summary

Immunogen
Mouse myeloma cell line NS0-derived recombinant mouse TRANCE/TNFSF11/RANK L
Arg72-Asp316
Accession # O35235
Specificity
Detects mouse TRANCE/TNFSF11/RANK L in ELISAs and Western blots.
Source
N/A
Isotype
IgG
Clonality
Polyclonal
Host
Goat
Gene
TNFSF11
Purity Statement
Antigen Affinity-purified
Endotoxin Note
<0.10 EU per 1 μg of the antibody by the LAL method.
Innovator's Reward
Test in a species/application not listed above to receive a full credit towards a future purchase.

Applications/Dilutions

Dilutions
  • ELISA Capture (Matched Antibody Pair) 0.2-0.8 ug/mL
  • ELISA Detection (Matched Antibody Pair) 0.1-0.4 ug/mL
  • ELISA Standard (Matched Pair)
  • Immunohistochemistry 5-15 ug/mL
  • Neutralization 0.02-0.06 ug/mL
  • Western Blot 0.1 ug/mL
Application Notes
ELISA Capture: Mouse TRANCE/TNFSF11/RANK L Antibody (Catalog # AF462)
ELISA Detection: Mouse TRANCE/TNFSF11/RANK L Biotinylated Antibody (Catalog # BAF462)
Standard: Recombinant Mouse TRANCE/TNFSF11/RANK L (Catalog # 462-TR)
Publications
Read Publications using
AF462 in the following applications:

Packaging, Storage & Formulations

Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Buffer
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.
Preservative
No Preservative
Concentration
LYOPH
Reconstitution Instructions
Reconstitute at 0.2 mg/mL in sterile PBS.

Notes

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for TRANCE/TNFSF11/RANK L Antibody [Unconjugated]

  • CD254 antigen
  • CD254
  • ODF
  • OPGL
  • OPGLOPTB2
  • Osteoclast differentiation factor
  • Osteoprotegerin ligand
  • RANK L
  • RANKL
  • RANKLreceptor activator of nuclear factor kappa B ligand
  • Receptor activator of nuclear factor kappa-B ligand
  • sOdf
  • TNF-related activation-induced cytokine
  • TNFSF11
  • TRANCE
  • TRANCEODFhRANKL2
  • tumor necrosis factor (ligand) superfamily, member 11
  • tumor necrosis factor ligand superfamily member 11

Background

TRANCE (receptor activator of NF-kappa B ligand [RANK L], also called TNF-related activation-induced cytokines, osteoprotegerin ligand [OPGL], and osteoclast differentiation factor [ODF]), is a member of the tumor necrosis factor (TNF) family. In the TNF superfamily nomenclature, TRANCE is referred to as TNFSF11. TRANCE was originally identified as an immediate early gene upregulated by T cell receptor stimulation. The murine TRANCE cDNA encodes a type II transmembrane protein of 316 amino acids with a predicted cytoplasmic domain of 48 amino acids and an extracellular domain of 247 amino acids. The extracellular domain contains two potential N-linked glycosylation sites. Mouse and human TRANCE share 85% amino acid identity. TRANCE is primarily expressed in T cells and T cell rich organs, such as thymus and lymph nodes. The multi-functions of TRANCE include induction of activation of the c-jun N-terminal kinase, enhancement of T cell growth and dendritic cell function, induction of osteoclastogenesis, and lymph node organogenesis. RANK is the cell surface signaling receptor of TRANCE. RANK has been shown to undergo receptor clustering during signal transduction. Osteoprotegerin, a soluble member of the TNF receptor family which binds TRANCE, is a naturally occurring decoy receptor that counterbalances the effects of TRANCE.

  1. Wong, B.R. et al. (1997) J. Biol. Chem. 272:25190.
  2. Anderson, D.M. et al. (1997) Nature 390:175.
  3. Nakagawa, N. et al. (1998) Biochem. Biophys. Res. Commun. 245:382.
  4. Kong, Y-Y. et al. (1999) Nature 397:315.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Customers Who Viewed This Item Also Viewed...

NB100-56508
Species: Av, Hu, Mu, Rt
Applications: CyTOF-ready, Flow-CS, Flow, IHC, IHC-P, WB
DY805
Species: Hu
Applications: ELISA
210-TA
Species: Hu
Applications: BA
D6050
Species: Hu
Applications: ELISA
DCDL40
Species: Hu
Applications: ELISA
NB100-56173
Species: Hu
Applications: Flow, ICC/IF, IHC, IHC-P, IP, WB
MAB1419
Species: Hu, Rt
Applications: CyTOF-ready, ICC, IHC, ICFlow
H00000054-D01P
Species: Hu, Mu
Applications: IHC, IHC-P, WB
H00057410-M02
Species: Hu, Mu, Rt
Applications: ELISA, S-ELISA, WB
NBP1-87315
Species: Hu
Applications: IHC, IHC-P
MAB7665
Species: Hu
Applications: IHC, WB
H00001513-M01
Species: Hu
Applications: ELISA, ICC/IF, IHC, IHC-P, WB
NB100-56583
Species: Hu, Rb, Rt
Applications: Flow, IHC, IHC-P, KO, WB
NB100-56732
Species: Hu, Mu
Applications: ICC/IF, IHC, Simple Western, WB
NBP1-47842
Species: Ca, Hu, Pm, Mu, Rt
Applications: IHC, IHC-P, IP, WB
NBP2-50037
Species: Hu, Mu, Rt
Applications: ICC/IF, IHC, KO, WB
NB300-164
Species: Ca, Hu, Mu, Po, Pm, Rt(-)
Applications: Dual ISH-IHC, ICC/IF, IHC, IHC-Fr, IHC-P, IP, PLA, WB
AF462
Species: Mu
Applications: WB, IHC, B/N, ELISA(Cap)

Publications for TRANCE/TNFSF11/RANK L Antibody (AF462)(21)

We have publications tested in 3 confirmed species: Human, Mouse, Transgenic Mouse.

We have publications tested in 5 applications: ELISA Development, ICC, IHC, IHC-P, Western Blot.


Filter By Application
ELISA Development
(1)
ICC
(1)
IHC
(4)
IHC-P
(7)
Western Blot
(8)
All Applications
Filter By Species
Human
(3)
Mouse
(17)
Transgenic Mouse
(1)
All Species
Showing Publications 1 - 10 of 21. Show All 21 Publications.
Publications using AF462 Applications Species
MM Szwarc, L Hai, VK Maurya, K Rajapakshe, D Perera, MM Ittmann, Q Mo, Y Lin, ML Bettini, C Coarfa, JP Lydon Histopathologic and transcriptomic phenotypes of a conditional RANKL transgenic mouse thymus Cytokine, 2022;160(0):156022. 2022 [PMID: 36099756] (Western Blot, Transgenic Mouse) Western Blot Transgenic Mouse
SH Lee, YHY Yap, CL Lim, ARE Woo, VCL Lin Activation function 1 of progesterone receptor is required for mammary development and regulation of RANKL during pregnancy Scientific Reports, 2022;12(1):12286. 2022 [PMID: 35854046] (IHC, Mouse) IHC Mouse
M Inoue, Y Nagai-Yosh, R Yamasaki, T Kawamoto, T Nishihara, W Ariyoshi Mechanisms involved in suppression of osteoclast supportive activity by transforming growth factor-beta1 via the ubiquitin-proteasome system PLoS ONE, 2022;17(2):e0262612. 2022 [PMID: 35196318] (Western Blot, Mouse) Western Blot Mouse
D Li, M San, J Zhang, A Yang, W Xie, Y Chen, X Lu, Y Zhang, M Zhao, X Feng, Y Zheng Oxytocin receptor induces mammary tumorigenesis through prolactin/p-STAT5 pathway Cell Death & Disease, 2021;12(6):588. 2021 [PMID: 34099636] (Western Blot, Mouse) Western Blot Mouse
HN Kim, J Xiong, RS MacLeod, S Iyer, Y Fujiwara, KM Cawley, L Han, Y He, JD Thostenson, E Ferreira, RL Jilka, D Zhou, M Almeida, CA O'Brien Osteocyte RANKL is required for cortical bone loss with age and is induced by senescence JCI Insight, 2020;0(0):. 2020 [PMID: 32870816] (Western Blot, Mouse) Western Blot Mouse
M Li, D Xu Antiresorptive activity of osteoprotegerin requires an intact heparan sulfate-binding site Proc. Natl. Acad. Sci. U.S.A., 2020;0(0):. 2020 [PMID: 32636266] (ICC, Mouse) ICC Mouse
R Pascual, J Martín, F Salvador, O Reina, V Chanes, A Millanes-R, C Suñer, G Fernández-, A Bartomeu, YS Huang, RR Gomis, R Méndez The RNA binding protein CPEB2 regulates hormone sensing in mammary gland development and luminal breast cancer Sci Adv, 2020;6(20):eaax3868. 2020 [PMID: 32440535] (IHC, Human) IHC Human
L Hai, MM Szwarc, DM Lonard, K Rajapakshe, D Perera, C Coarfa, M Ittmann, R Fernandez-, JP Lydon Short-term RANKL exposure initiates a neoplastic transcriptional program in the basal epithelium of the murine salivary gland Cytokine, 2019;123(0):154745. 2019 [PMID: 31226438] (IHC, Human) IHC Human
J Jhun, SH Lee, SY Kim, J Ryu, JY Kwon, HS Na, K Jung, SJ Moon, ML Cho, JK Min RIPK1 inhibition attenuates experimental autoimmune arthritis via suppression of osteoclastogenesis J Transl Med, 2019;17(1):84. 2019 [PMID: 30876479] (IHC-P, Mouse) IHC-P Mouse
J Xiong, K Cawley, M Piemontese, Y Fujiwara, H Zhao, JJ Goellner, CA O'Brien Soluble RANKL contributes to osteoclast formation in adult mice but not ovariectomy-induced bone loss Nat Commun, 2018;9(1):2909. 2018 [PMID: 30046091] (Western Blot, Mouse) Western Blot Mouse
Show All 21 Publications.

Reviews for TRANCE/TNFSF11/RANK L Antibody (AF462) (0)

There are no reviews for TRANCE/TNFSF11/RANK L Antibody (AF462). By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
  • Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
  • Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen

Product General Protocols

Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.

Video Protocols

WB Video Protocol

FAQs for TRANCE/TNFSF11/RANK L Antibody (AF462) (0)

There are no specific FAQs related to this product. Read our general customer & technical service FAQs.

Secondary Antibodies

 

Isotype Controls

Additional TRANCE/TNFSF11/RANK L Products

Bioinformatics Tool for TRANCE/TNFSF11/RANK L Antibody (AF462)

Discover related pathways, diseases and genes to TRANCE/TNFSF11/RANK L Antibody (AF462). Need help? Read the Bioinformatics Tool Guide for instructions on using this tool.
Visit Tool

Diseases for TRANCE/TNFSF11/RANK L Antibody (AF462)

Discover more about diseases related to TRANCE/TNFSF11/RANK L Antibody (AF462).
 

Pathways for TRANCE/TNFSF11/RANK L Antibody (AF462)

View related products by pathway.

PTMs for TRANCE/TNFSF11/RANK L Antibody (AF462)

Learn more about PTMs related to TRANCE/TNFSF11/RANK L Antibody (AF462).

Blogs on TRANCE/TNFSF11/RANK L.

The diverse functions of RANKL/TRANCE/TNFSF11
RANKL (also known as TNF-related activation-induced cytokine), or receptor activator of nuclear factor-?B ligand, was first discovered as a key player in the RANKL/RANK/OPG osteoclast formation pathway. Osteoclasts are large multinucleate cells t...  Read full blog post.

Download our IHC Handbook

Customers Who Bought This Also Bought

Contact Information

Product PDFs

Calculators

Concentration Calculator

The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.

=
÷

Review this Product

Be the first to review our TRANCE/TNFSF11/RANK L Antibody [Unconjugated] and receive a gift card or discount.

Bioinformatics

Gene Symbol TNFSF11
Uniprot